FRLN News

The IPO market is expected to remain active in the week ahead with nine IPOs scheduled to raise $2.7 billion.  Canadian digital service provider TELUS International (TIXT) plans to raise $800 million at a $6.4 billion market cap. The company provides customer service outsourcing and end-to-end customer experience and digital technology solutions and...read more

Eight IPOs and nine SPACs entered the public markets this past week led by BigCommerce (BIGC), which soared 201% in the best first-day pop for an IPO over $100 million in 15 years. E-commerce platform BigCommerce (BIGC) priced above the upwardly revised range to raise $216 million at a $1.8 billion market cap. With accelerating growth and...read more

Freeline Therapeutics, a Phase 1/2 biotech developing gene therapies for hemophilia and rare diseases, raised $159 million by offering 8.8 million shares at $18, the high end of the range of $16 to $18. The Stevenage, UK-based company offered 1.5 million more shares than anticipated. At pricing, Freeline Therapeutics commands a fully diluted market value of $636 million. ...read more

Freeline Therapeutics, a Phase 1/2 biotech developing gene therapies for rare diseases, announced terms for its IPO on Monday. The Stevenage, UK-based company plans to raise $125 million by offering 7.4 million ADSs at a price range of $16 to $18. At the midpoint of the proposed range, Freeline Therapeutics would command a fully diluted market value of $574 million. The...read more